ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 088

Quality Improvement Cycles to Actualize Distribution of the Adolescent Assessment of Preparation for Transition (ADAPT) Survey

David McDonald1, Kristiana Nasto1, Kyla Fergason1, Mary Robichaux1, Bernard Danna1, Monique Maher1, Alexander Alexander1, Ariel Coleman2, Anne Dykes2, JaLeen Rogers2, Miriah Gillispie-Taylor1 and Tiphanie Vogel1, 1Baylor College of Medicine, Houston, TX, 2Texas Children's Hospital, Houston, TX

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Health Services Research

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, March 30, 2023

Title: Posters: Quality, Health Services, and Education I

Session Type: Poster Session A

Session Time: 6:00PM-7:00PM

Background/Purpose: The challenges of transitioning patients with chronic rheumatic diseases from pediatric to adult care can lead to increased morbidity and mortality following transfer. Therefore, approaches to assess transition readiness are urgently needed, and should ideally be practical and sustainable. The Adolescent Assessment of Preparation for Transition (ADAPT) is a validated survey of patient self-reported transition readiness. Our overall goal was to implement a low-labor strategy by which 90% of transition-eligible patients complete an ADAPT survey at each visit.

Methods: Transition-eligible patients are age 14 years or older and attending a return clinic appointment. We conducted Plan-Do-Study-Act (PDSA) cycles using different methods of ADAPT survey distribution to eligible patients. Numbers of surveys distributed and rates of surveys returned during each PDSA cycle were calculated and compared.

Results: Our initial PDSA cycle distributed ADAPT surveys through a Research Electronic Data Capture (REDCap) database using email, requiring moderate weekly personnel effort yet achieving only 8% survey return rate (Table 1). In cycle 2, in-person coordinators increased the return rate to 30%. In March 2020, pandemic-related clinic closures and transition to telehealth necessitated a return to survey distribution by email (cycle 3). However, we observed an increase in survey return rate from cycle 1 by more than half (12.4%) despite using the same delivery method and have attributed this finding to increased patient/family familiarity with electronic clinic communications. The launch of telehealth inspired efforts to coordinate survey distribution using the electronic medical record (EMR). In cycle 4, providers could manually assign surveys to eligible patients while in the EMR. Results for returned surveys were obtained by monthly data pull, but did not capture the denominator of eligible patients. In cycle 5, the EMR was adjusted so that surveys are automatically launched to eligible patients prior to both in-person and telehealth appointments for completion via electronic clinic check-in. This method requires no personnel effort. Results are provided by monthly data pull and yielded 597/608 (98%) returned surveys in the first 8 months.

Conclusion: Using quality improvement cycles, we have created a fully automated method for assessment of patient self-reported transition readiness. Distribution through the EMR prior to appointments is efficient and effective. In the future, the ADAPT data we generate will allow us to assess for correlations between patient self-reported transition readiness and successful healthcare transition.

Supporting image 1


Disclosures: D. McDonald: None; K. Nasto: None; K. Fergason: None; M. Robichaux: None; B. Danna: None; M. Maher: None; A. Alexander: None; A. Coleman: None; A. Dykes: None; J. Rogers: None; M. Gillispie-Taylor: Pfizer, 5; T. Vogel: Moderna, 2, Novartis, 2, Pfizer, 2, sobi, 2.

To cite this abstract in AMA style:

McDonald D, Nasto K, Fergason K, Robichaux M, Danna B, Maher M, Alexander A, Coleman A, Dykes A, Rogers J, Gillispie-Taylor M, Vogel T. Quality Improvement Cycles to Actualize Distribution of the Adolescent Assessment of Preparation for Transition (ADAPT) Survey [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/quality-improvement-cycles-to-actualize-distribution-of-the-adolescent-assessment-of-preparation-for-transition-adapt-survey/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quality-improvement-cycles-to-actualize-distribution-of-the-adolescent-assessment-of-preparation-for-transition-adapt-survey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology